skip to main content
Primo Search
Search in: Busca Geral

Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors

Pfister, Christian ; Lacombe, Louis ; Vezina, Marie Claude ; Moore, Lynne ; Larue, Hélène ; Têtu, Bernard ; Meyer, François ; Fradet, Yves

Human pathology, 1999-11, Vol.30 (11), p.1350-1355 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
  • Título:
    Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors
  • Autor: Pfister, Christian ; Lacombe, Louis ; Vezina, Marie Claude ; Moore, Lynne ; Larue, Hélène ; Têtu, Bernard ; Meyer, François ; Fradet, Yves
  • Assuntos: Aged ; Biological and medical sciences ; bladder tumors recurrence ; Cell Division ; Disease-Free Survival ; DNA ploidy ; Female ; Flow Cytometry ; Humans ; Immunohistochemistry ; Ki-67 Antigen - metabolism ; Ki-67 index ; Male ; Medical sciences ; Neoplasm Recurrence, Local ; Nephrology. Urinary tract diseases ; Prognosis ; S Phase ; Tumors of the urinary system ; Urinary Bladder Neoplasms - metabolism ; Urinary Bladder Neoplasms - pathology ; Urinary Bladder Neoplasms - surgery ; Urinary tract. Prostate gland
  • É parte de: Human pathology, 1999-11, Vol.30 (11), p.1350-1355
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: The biological behavior of urothelial carcinomas remains unpredictable. The objective of this study was to determine the prognostic value of Ki-67 index in superficial papillary bladder tumors and to correlate it with the S-phase fraction (SPF) measured by flow cytometry. Three hundred nineteen patients with newly diagnosed superficial (pTa, pT1) bladder tumors were included between September 1990 and April 1992. Patients with bladder carcinoma in situ alone were excluded. We observed 255 pTa tumors and 64 pT1 tumors, whereas 111 lesions were classified as grade G1 and 208 as grade G2-G3, Ki-67 immunostaining was performend on paraffin-embedded material using a 3-step immunoperoxidase procedure with the murine monoclonal antibody MiB1. The relation between Ki-67 expression and prognostic variables (stage, grade, tumor size, multifocality, age, and sex) was investigated by the chi-square test. Cox regression was used to describe the association between Ki-67 and tumor recurrence in 308 patients with follow-up while adjusting for potentially confounding prognostic variables. The frequency of high Ki-67 expression (≥10%) increased with stage ( P = .005) and grade ( P = .001), but not with tumor size or multifocality. Two hundred one patients experienced tumor recurrence in a median follow-up of 68 mouths. Stage, grade, tumor size, and multifocality were all independent predictors of recurrence. Ki-67 index greater than 10% was found to be an independent predictor of tumor recurrence among patients with tumors larger than 3 cm in diameter (HR = 2.05, CI = 1.18-3.55), but not those with smaller size tumors. With regards to the DNA index, a significant but weak correlation was observed between Ki-67 expression and the SPF (Spearman's correlation coefficient = 0.23, P = .004). In addition, aneuploid tumors had significantly higher expression of Ki-67 (22.5%) than diploid tumors (10.1%) ( P = .0006). Moreover, patients with DNA aneuploid bladder tumors were more likely to have more than 10% Ki-67-positive cells than those with diploid tumors. In patients with newly diagnosed pTa or pT1 bladder tumors, a Ki-67 index above 10% is an independent predictor of shorter time to recurrence only in those with tumors larger than 3 cm.
  • Editor: New York, NY: Elsevier Inc
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.